Newlink Genetics reported $0 in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Bristol Myers Squibb BMY:US $ 37107M 343M
Capricor Therapeutics CAPR:US $ 3.38M 0M
Celldex Therapeutics CLDX:US $ 0M 0M
Eli Lilly And LLY:US $ 14692M 460.9M
Nektar Therapeutics NKTR:US $ 0M 0M
Prothena PRTA:US 0 0
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
YTE INCY:US $ 31.16M 0.23M